Navigation Links
Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
Date:11/5/2007

e lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using Haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes.

Synvista Therapeutics also is developing alagebrium, a proposed breaker of AGEs for the treatment of diastolic heart failure. This disease represents a rapidly growing market of unmet medical need, particularly common among diabetic patients. Alagebrium has demonstrated relevant clinical activity in two Phase 2 clinical trials in heart failure, as well as in animal models of heart failure and nephropathy, among others. Alagebrium has been tested in approximately 1,000 patients in multiple Phase 1 and Phase 2 clinical trials, allowing Synvista Therapeutics to assemble a sizeable human safety database. For more information, please visit the Company's website at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future clinical development of Synvista Therapeutics' product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2006. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may di
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Medical ... provides separate comprehensive analytics for the US, ... Rest of World. Annual estimates and forecasts are provided ... historic analysis is provided for these markets. Market data ... Company profiles are primarily based on public domain information ...
(Date:4/20/2015)... April 20, 2015  SillaJen, Inc., a private ... oncolytic immunotherapy products for cancer, today announced an ... Annual Meeting of the American Association for Cancer ... adapted version of its lead product candidate, Pexa-Vec ... an oncolytic immunotherapy designed to 1) rapidly de-bulk ...
(Date:4/20/2015)... EXTON, Pa. , April 20, 2015 The ... leader in pharmacokinetic testing of drugs and safety testing of ... , will present at this week,s workshop " Drug Transporters ... Baltimore, MD . The title of Dr. ... Transporters," part of a session entitled "Transporter Tools of the ...
Breaking Medicine Technology:World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2
... YORK, May 12, 2011 Reportlinker.com announces ... available in its catalogue: ... 2017 http://www.reportlinker.com/p0493115/Asia-Pacific-Hospital-Supplies-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Outlook to 2017 Summary ...
... Korea, May 11, 2011 CrystalGenomics, Inc., a biopharmaceutical ... that the draft Clinical Study Report (CSR) from CG400549,s ... been received. CG400549 is a potential first-in-class ... a critical enzyme in generating bacterial membrane and has ...
Cached Medicine Technology:Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 2Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 3Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 4Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 5Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 6Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 7Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 8Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 9Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 10Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 11Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 12Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 13Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 14Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 15CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 2
(Date:4/20/2015)... April 20, 2015 Saint Joseph Regional Medical ... Top Health Systems by Truven Health Analytics, a leading provider ... of healthcare. SJRMC has been recognized by Truven Health Analytics ... past four years. , According to Truven Health Analytics' ... Systems, in matchups with their peers, set the standard for ...
(Date:4/20/2015)... At the famous Avalon Hollywood on April 8th, ... Lounge, with Choices Recovery as the premier sponsor. Organizer ... placement in TV and film, gathered some of the ... goods and services for this daylong event. , ... Celebrity Interview Lounge, speaking with many of the notable ...
(Date:4/20/2015)... 20, 2015 Novatus, a leading ... expanded its service level to the growing European ... Amsterdam and Paris. After a rigorous review ... levels of resilience, security and operational expertise, and ... for Novatus as we expand our footprint and ...
(Date:4/20/2015)... FL (PRWEB) April 20, 2015 Florida ... to receive three prestigious awards from Select Medical, during ... Tampa on Friday, April 10th. Chief Operating Officer, Debi ... stable leadership. She was one of six recipients out ... the Stu Dinney Humanitarian Award for the contributions to ...
(Date:4/20/2015)... April 20, 2015 Today the ... Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer ... Dream Team will focus on “DNA Repair Therapies ... have identified DNA repair as a common weakness ... prevention and early detection of ovarian cancer by ...
Breaking Medicine News(10 mins):Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2Health News:Novatus Expands into European Data Centers 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4
... ... New York personal injury attorney, David Perecman. , ... New York, NY (PRWEB) July 14, 2009 -- Three workers, including a ... accident at a privately operated waste transfer plant in Jamaica, Queens. All three apparently ...
... , , LAKEWOOD, Colo., July 14 ... has been named to the Fortune Small Business Magazine,s (FSB) annual list ... Every year the editors of FSB analyze public companies with annual revenues ... revenues and stock performance over the past three years. This is ...
... July 14 The A.M. McGregor Group, a direct provider and benefactor ... House - a 25-bed nursing facility atop Cedar Hill near University Circle ... The facility, in the City of Cleveland on the boundary of ... in early fall as McGregor at Overlook. , ...
... Irvine, Calif., July 14, 2009 A drug similar to ... and psoriasis has been found to rescue memory in mice ... offers hope that a new treatment may be on the ... leading cause of elderly dementia afflicting more than 5 million ...
... ARBOR, Mich., July 14 As the recent decline in ... care search engine is making it even easier for families to ... launch of their ElderCare Library and ... http://www.thecaringspace.com ) provides an industry-leading set of resources that empowers its ...
... , , , HULL, ... (NYSE: SNN ) announced that the UK Court of Appeal ... patent EP 0 626 720 that is licensed to Kinetic Concepts, Inc. (NYSE: ... & Nephew,s RENASYS(TM)-F NPWT system has been lifted. , ...
Cached Medicine News:Health News:Personal Injury Attorneys Contemplate Toxic Evidence in the Death of 3 Men in New York 2Health News:Personal Injury Attorneys Contemplate Toxic Evidence in the Death of 3 Men in New York 3Health News:Fortune Names Mesa Laboratories as one of America's Fastest Growing Small Public Companies 2Health News:The McGregor Group to Reopen Overlook House in Cleveland as a New Nursing Facility 2Health News:Drug rescues memory lost to Alzheimer's disease 2Health News:Leading Senior Care Destination TheCaringSpace.com Launches ElderCare Library and Care Community 2Health News:UK Court of Appeal Rules in Smith & Nephew's Favour 2Health News:UK Court of Appeal Rules in Smith & Nephew's Favour 3
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
96-well Silicone Compression Mat, Bulk...
Silicone Compression Mat, Bulk...
96-well Silicone Expansion Mat, Bulk...
Medicine Products: